Importantly, western blotting analysis of the xenograft tumors treated with the triple combination showed lower levels of p-Rb S780 and substantially higher levels of cleaved PARP (Fig. 6f, g), supporting the anti-tumor activity reported in vitro (Fig. 4). Here, RB1 is linked to neoplasm.